Dilated cardiomyopathy: An unusual complication of clozapine therapy

Nature Clinical Practice Cardiovascular Medicine

Volumn 5, Issue 9, 2008, Pages 566-570

  Makhoul, Badira ^a   Hochberg, Irit ^b   Rispler, Shmuel ^c   Azzam, Zaher S ^d  

^a Rambam Health Care Campus ^*  (Israel)

^b INSTITUTE OF ENDOCRINOLOGY   (Israel)

^c Heart Institute   (Israel)

^d Rambam Health Care Campus   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CREATININE; FUROSEMIDE; METOPROLOL SUCCINATE; MORPHINE; NESIRITIDE; RAMIPRIL; SPIRONOLACTONE; UREA;

ABNORMAL RESPIRATORY SOUND; ADULT; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY; EVENING DOSAGE; FATIGUE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPONATREMIA; LEG EDEMA; LUNG EDEMA; MALE; MORNING DOSAGE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE DRUG DOSE; SINUS TACHYCARDIA; SYSTOLIC DYSFUNCTION; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; UREA BLOOD LEVEL; UREMIA;

ADMINISTRATION, ORAL; ADULT; ANTIPSYCHOTIC AGENTS; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; CLOZAPINE; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PULMONARY EDEMA; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 50649107046     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1292     Document Type: Article

References (16)

1. Naranjo CA et al. (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245
2. Felker GM et al. (1999) The spectrum of dilated cardiomyopathy: the Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 78: 270-283
3. Kane J et al. (1988) Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789-796
4. Coulter DM et al. (2001) Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: Data mining study. BMJ 322: 1207-1209
5. Wehmeier PM et al. (2005) Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. J Clin Pharm Ther 30: 91-96
6. Wooltorton E (2002) Antipsychotic clozapine (Clozaril): Myocarditis and cardiovascular toxicity. CMAJ 166: 1185-1186
7. Tanner MA and Culling W (2003) Clozapine associated dilated cardiomyopathy. Postgrad Med J 79: 412-413
8. Phan KL and Taylor SF (2002) Clozapine-associated cardiomyopathy. Psychosomatics 43: 248
9. Leo RJ et al. (1996) Cardiomyopathy associated with clozapine. Ann Pharmacother 30: 603-605
10. Merrill DB et al. (2005) Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol 25: 32-41
11. Sechtem U et al. (2007) Cardiac magnetic resonance in myocardial disease. Heart 93: 1520-1527
12. Cooper LT et al. (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116: 2216-2233
13. Kühl U et al. (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970
14. Williams DP et al. (2003) Bioactivation of clozapine by murine cardiac tissue in vivo and in vitro. Chem Res Toxicol 16 1359-1364
15. Vaddadi KS et al. (2003) Low blood selenium concentrations in schizophrenic patients on clozapine. Br J Clin Pharmacol 55: 307-309
16. Killian JG et al. (1999) Myocarditis and cardiomyopathy associated with clozapine. Lancet 354: 1841-1845